Laser-assisted microdissection in translational research: Theory, technical considerations, and future applications

Applied Immunohistochemistry and Molecular Morphology

Volumn 21, Issue 1, 2013, Pages 31-47

  Cheng, Liang ^a   Zhang, Shaobo ^a   MacLennan, Gregory T ^b   Williamson, Sean R ^a   Davidson, Darrell D ^a   Wang, Mingsheng ^a   Jones, Timothy D ^c   Lopez Beltran, Antonio ^d   Montironi, Rodolfo ^e  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Floyd Memorial Hospital and Health Services   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CÓRDOBA   (Spain)

^e UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

cancer heterogeneity; carcinogenesis; gene expression profiling; genome characterization alteration; laser capture microdissection; personalized medicine; proteomics; targeted therapy

Indexed keywords

DNA; MICRORNA; RNA;

ARTIFICIAL MEMBRANE; CANCER PROGNOSIS; CARCINOGENESIS; CHEMOPROPHYLAXIS; CLONAL VARIATION; COLD LASER SYSTEM; DENATURATION; DNA DETERMINATION; DNA EXTRACTION; DNA METHYLATION; EPIGENETICS; FROZEN SECTION; GENE EXPRESSION PROFILING; GENE MUTATION; INFRARED LASER; LASER; LASER CAPTURE MICRODISSECTION; PRIORITY JOURNAL; PROCESS DESIGN; PROTEIN DEGRADATION; REVIEW; RNA EXTRACTION; THERMAL SENSITIVE MEMBRANE; TISSUE FIXATION; TRANSLATIONAL RESEARCH; TUMOR DIAGNOSIS; ULTRAVIOLET LASER SYSTEM; X CHROMOSOME INACTIVATION;

DNA; EPIGENOMICS; GENE EXPRESSION PROFILING; HUMANS; LASER CAPTURE MICRODISSECTION; MOLECULAR TARGETED THERAPY; NEOPLASMS; PROTEINS; RNA; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84872005086     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e31824d0519     Document Type: Review

References (114)

1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57-70. (Pubitemid 30046295)
2. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646-674.
3. Cheng L, Zhang S, Wang M, et al. Molecular genetic evidence supporting the neoplastic nature of stromal cells in 'fibrosis' after chemotherapy for testicular germ cell tumours. J Pathol. 2007;213: 65-71. (Pubitemid 47354567)
4. Cheng L, Zhang D. Molecular Genetic Pathology. Totowa, NJ: Humana Press/Springer; 2008.
5. Cheng L, Neumann RM, Nehra A, et al. Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma. Cancer. 2000;88:1663-1670. (Pubitemid 30183152)
6. Katona TM, Jones TD, Wang M, et al. Genetically heterogeneous and clonally unrelated metastases may arise in patients with cutaneous melanoma. Am J Surg Pathol. 2007;31:1029-1037. (Pubitemid 47012299)
7. Jones TD, Eble JN, Wang M, et al. Clonal divergence and genetic heterogeneity in clear cell renal cell carcinomas with sarcomatoid transformation. Cancer. 2005;104:1195-1203. (Pubitemid 41278954)
8. Andreoiu M, Cheng L. Multifocal prostate cancer: biologic, prognostic, and therapeutic implications. Hum Pathol. 2010;41: 781-793.
9. Cheng L, Zhang S, Maclennan GT, et al. Bladder cancer: translating molecular genetic insights into clinical practice. Hum Pathol. 2011;42:455-481.
10. Cheng L, Zhang S, MacLennan GT, et al. Molecular and cytogenetic insights into the pathogenesis, classification, differential diagnosis, and prognosis of renal epithelial neoplasms. Hum Pathol. 2009;40:10-29.
11. Kuhar M, Cheng L. Laser capture microdissection. In: Cheng L, Zhang D, eds. Molecular Genetic Pathology. 2nd ed. Totowa, NJ: Humana Press/Springer; 2008:141-154.
12. Hernandez S, Lloreta J. Manual versus laser micro-dissection in molecular biology. Ultrastruct Pathol. 2006;30:221-228. (Pubitemid 44049777)
13. Simone NL, Bonner RF, Gillespie JW, et al. Laser-capture microdissection: opening the microscopic frontier to molecular analysis. Trends Genet. 1998;14:272-276. (Pubitemid 28341788)
14. Maitra A, Gazdar AF. Tissue microdissection and processing. Cancer Treat Res. 2001;106:63-84.
15. Hunt JL, Finkelstein SD. Microdissection techniques for molecular testing in surgical pathology. Arch Pathol Lab Med. 2004;128: 1372-1378. (Pubitemid 39627474)
16. Espina V, Wulfkuhle JD, Calvert VS, et al. Laser-capture microdissection. Nat Protoc. 2006;1:586-603.
17. Lowry OH, Passonneau JV. A Flexible System of Enzymatic Analysis. New York: Academic Press; 1972.
18. Goelz SE, Hamilton SR, Vogelstein B. Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. Biochem Biophys Res Commun. 1985;130:118-126. (Pubitemid 15249008)
19. Meier-Ruge W, Bielser W, Remy E, et al. The laser in the Lowry technique for microdissection of freeze-dried tissue slices. Histo-chem J. 1976;8:387-401.
20. Emmert-Buck MR, Bonner RF, Smith PD, et al. Laser capture microdissection. Science. 1996;274:998-1001. (Pubitemid 26398425)
21. Suarez-Quian CA, Goldstein SR, Bonner RF. Laser capture microdissection: a new tool for the study of spermatogenesis. J Androl. 2000;21:601-608.
22. Espina V, Heiby M, Pierobon M, et al. Laser capture micro-dissection technology. Expert Rev Mol Diagn. 2007;7:647-657.
23. Espina V, Milia J, Wu G, et al. Laser capture microdissection. Methods Mol Biol. 2006;319:213-229.
24. Maitra A, Wistuba II, Virmani AK, et al. Enrichment of epithelial cells for molecular studies. Nat Med. 1999;5:459-463. (Pubitemid 29180589)
25. Maitra A, Wistuba II, Gazdar AF. Microdissection and the study of cancer pathways. Curr Mol Med. 2001;1:153-162. (Pubitemid 33772975)
26. Craven RA, Banks RE. Laser capture microdissection and proteo-mics: possibilities and limitation. Proteomics. 2001;1:1200-1204.
27. Best CJ, Emmert-Buck MR. Molecular profiling of tissue samples using laser capture microdissection. Expert Rev Mol Diagn. 2001;1:53-60. (Pubitemid 34654447)
28. Gjerdrum LM, Lielpetere I, Rasmussen LM, et al. Laser-assisted microdissection of membrane-mounted paraffin sections for polymerase chain reaction analysis: identification of cell populations using immunohistochemistry and in situ hybridization. J Mol Diagn. 2001;3:105-110. (Pubitemid 32771509)
29. Goldsworthy SM, Stockton PS, Trempus CS, et al. Effects of fixation on RNA extraction and amplification from laser capture microdissected tissue. Mol Carcinog. 1999;25:86-91. (Pubitemid 29275020)
30. Tangrea MA, Chuaqui RF, Gillespie JW, et al. Expression microdissection: operator-independent retrieval of cells for molecular profiling. Diagn Mol Pathol. 2004;13:207-212. (Pubitemid 39552241)
31. Hanson JC, Tangrea MA, Kim S, et al. Expression microdissection adapted to commercial laser dissection instruments. Nat Protoc. 2011;6:457-467.
32. Cheng L, MacLennan GT, Zhang S, et al. Laser capture microdissection analysis reveals frequent allelic losses in papillary urothelial neoplasm of low malignant potential of the urinary bladder. Cancer. 2004;101:183-188. (Pubitemid 38812439)
33. Verlinden I, Janssens J, Raus J, et al. Microdissection and SAGE as a combined tool to reveal gene expression in ductal carcinoma in situ of the breast. Mol Carcinog. 2004;41:197-206. (Pubitemid 39552707)
34. Harsch M, Bendrat K, Hofmeier G, et al. A new method for histological microdissection utilizing an ultrasonically oscillating needle: demonstrated by differential mRNA expression in human lung carcinoma tissue. Am J Pathol. 2001;158:1985-1990. (Pubitemid 32545183)
35. Burgess JK, Hazelton RH. New developments in the analysis of gene expression. Redox Rep. 2000;5:63-73. (Pubitemid 30487972)
36. Espina V, Geho D, Mehta AI, et al. Pathology of the future: molecular profiling for targeted therapy. Cancer Invest. 2005;23: 36-46. (Pubitemid 40344199)
37. Patel V, Hood BL, Molinolo AA, et al. Proteomic analysis of laser-captured paraffin-embedded tissues: a molecular portrait of head and neck cancer progression. Clin Cancer Res. 2008;14:1002-1014. (Pubitemid 351302545)
38. Cheng AL, Huang WG, Chen ZC, et al. Identification of novel nasopharyngeal carcinoma biomarkers by laser capture micro-dissection and proteomic analysis. Clin Cancer Res. 2008;14: 435-445.
39. Wang H, Owens JD, Shih JH, et al. Histological staining methods preparatory to laser capture microdissection significantly affect the integrity of the cellular RNA. BMC Genomics. 2006;7:97.
40. Sonne SB, Dalgaard MD, Nielsen JE, et al. Optimizing staining protocols for laser microdissection of specific cell types from the testis including carcinoma in situ. PLoS One. 2009;4:e5536.
41. Rodriguez-Rigueiro T, Valladares-Ayerbes M, Haz-Conde M, et al. A novel procedure for protein extraction from formalin-fixed paraffin-embedded tissues. Proteomics. 2011;11:2555-2559.
42. Scicchitano MS, Dalmas DA, Boyce RW, et al. Protein extraction of formalin-fixed, paraffin-embedded tissue enables robust proteo-mic profiles by mass spectrometry. J Histochem Cytochem. 2009;57: 849-860.
43. Xie R, Chung JY, Ylaya K, et al. Factors influencing the degradation of archival formalin-fixed paraffin-embedded tissue sections. J Histochem Cytochem. 2011;59:356-365.
44. Tangrea MA, Mukherjee S, Gao B, et al. Effect of immunohis-tochemistry on molecular analysis of tissue samples: implications for microdissection technologies. J Histochem Cytochem. 2011;59: 591-600.
45. Ikeda K, Monden T, Kanoh T, et al. Extraction and analysis of diagnostically useful proteins from formalin-fixed, paraffin-embedded tissue sections. J Histochem Cytochem. 1998;46:397-403. (Pubitemid 28117390)
46. Araki T, Yamamoto A, Yamada M. Accurate determination of DNA content in single cell nuclei stained with Hoechst 33258 fluorochrome at high salt concentration. Histochemistry. 1987;87: 331-338.
47. Lawrie LC, Curran S, McLeod HL, et al. Application of laser capture microdissection and proteomics in colon cancer. Mol Pathol. 2001;54:253-258. (Pubitemid 32730402)
48. Suarez-Quian CA, Goldstein SR, Pohida T, et al. Laser capture microdissection of single cells from complex tissues. Biotechniques. 1999;26:328-335. (Pubitemid 29072480)
49. Craven RA, Totty N, Harnden P, et al. Laser capture micro-dissection and two-dimensional polyacrylamide gel electrophoresis: evaluation of tissue preparation and sample limitations. Am J Pathol. 2002;160:815-822. (Pubitemid 34224571)
50. Ornstein DK, Englert C, Gillespie JW, et al. Characterization of intracellular prostate-specific antigen from laser capture microdissected benign and malignant prostatic epithelium. Clin Cancer Res. 2000;6:353-356. (Pubitemid 30111450)
51. Simone NL, Paweletz CP, Charboneau L, et al. Laser capture microdissection: beyond functional genomics to proteomics. Mol Diagn. 2000;5:301-307. (Pubitemid 32622202)
52. Craven RA, Banks RE. Use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis. Methods Enzymol. 2002;356:33-49. (Pubitemid 35217222)
53. McCarthy RP, Zhang S, Bostwick DG, et al. Molecular genetic evidence for different clonal origins of epithelial and stromal components of phyllodes tumor of the prostate. Am J Pathol. 2004;165:1395-1400. (Pubitemid 39297743)
54. Cheng L, Gu J, Ulbright TM, et al. Precise microdissection of human bladder carcinomas reveals divergent tumor subclones in the same tumor. Cancer. 2002;94:104-110. (Pubitemid 34049047)
55. Standaert DG. Applications of laser capture microdissection in the study of neurodegenerative disease. Arch Neurol. 2005;62:203-205. (Pubitemid 40204741)
56. Knudson AG. Two genetic hits (more or less) to cancer. Nat Rev Cancer. 2001;1:157-162. (Pubitemid 33741891)
57. Henley J, Summerlin DJ, Tomich C, et al. Molecular evidence supporting the neoplastic nature of odontogenic keratocyst: a laser capture microdissection study of 15 cases. Histopathology. 2005;47:582-586. (Pubitemid 41775180)
58. Younger C, Ulbright TM, Zhang S, et al. Molecular evidence supporting the neoplastic nature of some epidermoid cysts of the testis. Arch Pathol Lab Med. 2003;127:858-860. (Pubitemid 36792315)
59. Cheng L, Alexander R, Zhang S, et al. The clinical and therapeutic implications of cancer stem cell biology. Expert Rev Anticancer Ther. 2011;11:1131-1143.
60. Dahse R, Gartner D, Werner W, et al. P53 mutations as an identification marker for the clonal origin of bladder tumors and its recurrences. Oncol Rep. 2003;10:2033-2037.
61. Denzinger S, Mohren K, Knuechel R, et al. Improved clonality analysis of multifocal bladder tumors by combination of histopatho-logic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analyses. Hum Pathol. 2006;37:143-151. (Pubitemid 43099833)
62. Duggan BJ, Gray SB, McKnight JJ, et al. Oligoclonality in bladder cancer: the implication for molecular therapies. J Urol. 2004;171: 419-425. (Pubitemid 37549202)
63. Wang X, Wang M, MacLennan GT, et al. Evidence for common clonal origin of multifocal lung cancers. J Natl Cancer Inst. 2009;101:560-570.
64. McCarthy RP, Wang M, Jones TD, et al. Molecular evidence for the same clonal origin of multifocal papillary thyroid carcinomas. Clin Cancer Res. 2006;12:2414-2418.
65. Katona TM, Jones TD, Wang M, et al. Molecular evidence for independent origin of multifocal neuroendocrine tumors of the enteropancreatic axis. Cancer Res. 2006;66:4936-4942.
66. Jones TD, Wang M, Sung MT, et al. Clonal origin of metastatic testicular teratomas. Clin Cancer Res. 2006;12:5377-5383. (Pubitemid 44497251)
67. Jones T, Carr M, Eble JN, et al. Clonal origin of lymph node metastases in bladder carcinoma. Cancer. 2005;104:1901-1910. (Pubitemid 41513173)
68. Kernek KM, Ulbright TM, Zhang S, et al. Identical allelic losses in mature teratoma and other histologic components of malignant mixed germ cell tumors of the testis. Am J Pathol. 2003;163: 2477-2484. (Pubitemid 37466488)
69. Kum JB, Grignon DJ, Wang M, et al. Mixed epithelial and stromal tumors of the kidney: evidence for a single cell of origin with capacity for epithelial and stromal differentiation. Am J Surg Pathol. 2011;35:1114-1122.
70. Cheng L, Shan A, Cheville JC, et al. Atypical adenomatous hyperplasia of the prostate: a premalignant lesion? Cancer Res. 1998;58:389-391. (Pubitemid 28087394)
71. Oda S, Oki E, Maehara Y, et al. Precise assessment of micro-satellite instability using high resolution fluorescent microsatellite analysis. Nucleic Acids Res. 1997;25:3415-3420. (Pubitemid 27359214)
72. Emerson RE, Ulbright TM, Zhang S, et al. Nephroblastoma arising in a germ cell tumor of testicular origin. Am J Surg Pathol. 2004;28:687-692. (Pubitemid 38579574)
73. Cheng L, Jones TD, McCarthy RP, et al. Molecular genetic evidence for a common clonal origin of urinary bladder small cell carcinoma and coexisting urothelial carcinoma. Am J Pathol. 2005;166:1533-1539. (Pubitemid 40586521)
74. Sung MT, Wang M, Maclennan G, et al. Histogenesis of sarcomatoid urothelial carcinoma of the urinary bladder: evidence for a common clonal origin with divergent differentiation. J Pathol. 2007;211:420-430. (Pubitemid 46332553)
75. Jones TD, Eble JN, Cheng L. Application of molecular diagnostic techniques to renal epithelial neoplasms. Clin Lab Med. 2005;25:279-303. (Pubitemid 40545820)
76. Wang T, Chen YH, Hong H, et al. Increased nucleotide polymorphic changes in the 5-untranslated region of delta-catenin (CTNND2) gene in prostate cancer. Oncogene. 2009;28:555-564.
77. Sung MT, Zhang S, MacLennan GT, et al. Histogenesis of clear cell adenocarcinoma in the urinary tract: evidence of urothelial origin. Clin Cancer Res. 2008;14:1947-1955. (Pubitemid 351551103)
78. Jones TD, Wang M, Eble JN, et al. Molecular evidence supporting field effect in urothelial carcinogenesis. Clin Cancer Res. 2005;11:6512-6519. (Pubitemid 41338989)
79. Jones TD, Eble JN, Wang M, et al. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas. Clin Cancer Res. 2005;11: 7226-7233. (Pubitemid 41507679)
80. Emerson RE, Wang M, Roth LM, et al. Molecular genetic evidence supporting the neoplastic nature of the Leydig cell component of ovarian Sertoli-Leydig cell tumors. Int J Gynecol Pathol. 2007;26:368-374. (Pubitemid 47476320)
81. Jones TD, Carr MD, Eble JN, et al. Clonal origin of lymph node metastases in bladder carcinoma. Cancer. 2005;104:1901-1910. (Pubitemid 41513173)
82. Armstrong AB, Wang M, Eble JN, et al. TP53 mutational analysis supports monoclonal origin of biphasic sarcomatoid urothelial carcinoma (carcinosarcoma) of the urinary bladder. Mod Pathol. 2009;22:113-118.
83. Demuth T, Reavie LB, Rennert JL, et al. MAP-ing glioma invasion: mitogen-activated protein kinase kinase 3 and p38 drive glioma invasion and progression and predict patient survival. Mol Cancer Ther. 2007;6:1212-1222. (Pubitemid 46711984)
84. Jones PA, Baylin SB. The epigenomics of cancer. Cell. 2007;128:683-692. (Pubitemid 46273572)
85. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002;3:415-428. (Pubitemid 34587077)
86. Abbosh PH, Wang M, Eble JN, et al. Hypermethylation of tumor suppressor gene CpG islands in small cell carcinoma of the urinary bladder. Mod Pathol. 2008;21:355-362. (Pubitemid 351304290)
87. Cardoso J, Molenaar L, de Menezes RX, et al. Genomic profiling by DNA amplification of laser capture microdissected tissues and array CGH. Nucleic Acids Res. 2004;32:e146.
88. Tsukamoto Y, Uchida T, Karnan S, et al. Genome-wide analysis of DNA copy number alterations and gene expression in gastric cancer. J Pathol. 2008;216:471-482.
89. Hong WK, Endicott J, Itri LM, et al. 13-cis-retinoic acid in the treatment of oral leukoplakia. N Engl J Med. 1986;315: 1501-1505. (Pubitemid 17052146)
90. Mao L, Lee DJ, Tockman MS, et al. Microsatellite alterations as clonal markers for the detection of human cancer. Proc Natl Acad Sci USA. 1994;91:9871-9875. (Pubitemid 24311910)
91. Sluka P, O'Donnell L, McLachlan RI, et al. Application of laser-capture microdissection to analysis of gene expression in the testis. Prog Histochem Cytochem. 2008;42:173-201.
92. Luzzi V, Mahadevappa M, Raja R, et al. Accurate and reproducible gene expression profiles from laser capture micro-dissection, transcript amplification, and high density oligonucleo-tide microarray analysis. J Mol Diagn. 2003;5:9-14. (Pubitemid 36192994)
93. Castro NP, Osorio CA, Torres C, et al. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma. Breast Cancer Res. 2008;10:R87.
94. Sung MT, Lopez-Beltran A, Eble JN, et al. Divergent pathway of intestinal metaplasia and cystitis glandularis of the urinary bladder. Mod Pathol. 2006;19:1395-1401. (Pubitemid 44624156)
95. Oku Y, Shimoji T, Takifuji K, et al. Identification of the molecular mechanisms for dedifferentiation at the invasion front of colorectal cancer by a gene expression analysis. Clin Cancer Res. 2008;14:7215-7222.
96. Leja J, Essaghir A, Essand M, et al. Novel markers for enterochromaffin cells and gastrointestinal neuroendocrine carcinomas. Mod Pathol. 2009;22:261-272.
97. Sabo E, Meitner PA, Tavares R, et al. Expression analysis of Barrett's esophagus-associated high-grade dysplasia in laser capture microdissected archival tissue. Clin Cancer Res. 2008; 14:6440-6448.
98. Savci-Heijink CD, Kosari F, Aubry MC, et al. The role of desmoglein-3 in the diagnosis of squamous cell carcinoma of the lung. Am J Pathol. 2009;174:1629-1637.
99. Kosari F, Munz JM, Savci-Heijink CD, et al. Identification of prognostic biomarkers for prostate cancer. Clin Cancer Res. 2008;14:1734-1743. (Pubitemid 351469458)
100. Sgroi DC, Teng S, Robinson G, et al. In vivo gene expression profile analysis of human breast cancer progression. Cancer Res. 1999;59:5656-5661.
101. Ma XJ, Hilsenbeck SG, Wang W, et al. The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer. J Clin Oncol. 2006;24:4611-4619. (Pubitemid 46630959)
102. Makino H, Uetake H, Danenberg K, et al. Efficacy of laser capture microdissection plus RT-PCR technique in analyzing gene expression levels in human gastric cancer and colon cancer. BMC Cancer. 2008;8:210.
103. Roulhac PL, Ward JM, Thompson JW, et al. Microproteomics: quantitative proteomic profiling of small numbers of laser-captured cells. Cold Spring Harb Protoc. 2011. pdb.prot5573. doi: 10.1101/pdb.prot5573.
104. Meltzer PS. Cancer genomics: small RNAs with big impacts. Nature. 2005;435:745-746. (Pubitemid 40839710)
105. Croce CM, Calin GA. miRNAs, cancer, and stem cell division. Cell. 2005;122:6-7. (Pubitemid 40977933)
106. Hatfield SD, Shcherbata HR, Fischer KA, et al. Stem cell division is regulated by the microRNA pathway. Nature. 2005;435:974-978. (Pubitemid 40896325)
107. He L, Thomson JM, Hemann MT, et al. A microRNA polycistron as a potential human oncogene. Nature. 2005;435:828-833. (Pubitemid 40839734)
108. Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435:834-838. (Pubitemid 40839735)
109. Kobayashi M, Kawachi H, Takizawa T, et al. p53 mutation analysis of low-grade dysplasia and high-grade dysplasia/carcino-ma in situ of the esophagus using laser capture microdissection. Oncology. 2006;71:237-245. (Pubitemid 47289584)
110. Zheng S, Cummings OW, Saxena R, et al. Clonality and TP53 mutation analysis of focal nodular hyperplasia of the liver. Am J Clin Pathol. 2010;134:65-70.
111. Pinto AP, Miron A, Yassin Y, et al. Differentiated vulvar intraepithelial neoplasia contains Tp53 mutations and is genetically linked to vulvar squamous cell carcinoma. Mod Pathol. 2010; 23:404-412.
112. De Preter K, Vandesompele J, Heimann P, et al. Application of laser capture microdissection in genetic analysis of neuroblastoma and neuroblastoma precursor cells. Cancer Lett. 2003;197:53-61. (Pubitemid 36859990)
113. Yazdi AS, Puchta U, Flaig MJ, et al. Laser-capture micro-dissection: applications in routine molecular dermatopathology. J Cutan Pathol. 2004;31:465-470. (Pubitemid 38969702)
114. Finak G, Bertos N, Pepin F, et al. Stromal gene expression predicts clinical outcome in breast cancer. Nat Med. 2008;14:518-527. (Pubitemid 351655218)